Cargando…
MON-474 Dipeptidyl Peptidase-4 (DPP4) Inhibition Decreases Visceral Fat and Improves Glucose Metabolism in Overweight Women with Polycystic Ovarian Syndrome
Background: Women with PCOS have decreased GH secretion.(1) Diminished GH is associated with increased visceral adiposity and impaired vascular function. GH releasing hormone is the primary stimulus for GH secretion and a substrate of dipeptidyl peptidase-4 (DPP4).(2) We tested the hypothesis that o...
Autores principales: | Devin, Jessica, Nian, Hui, Wright, Patricia, Brown, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551164/ http://dx.doi.org/10.1210/js.2019-MON-474 |
Ejemplares similares
-
SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline
por: Madan Paramasivan, Ameena, et al.
Publicado: (2019) -
Analysis of the Relationship Between Learning and Synaptophysin in Obese Rats Treated With DPP4 Inhibitor
por: Korkmaz, Murat, et al.
Publicado: (2021) -
SUN-474 Estradiol Protects Against High-Fat Diet-Induced Obesity and Anxiety in Female Mice
por: Graham, Madeline, et al.
Publicado: (2019) -
MON-321 AgRP and Food Cravings Decrease with Treatment of Cushing’s Disease
por: Haseltine, Katherine N, et al.
Publicado: (2020) -
MON-269 FGFR-4 Expression in Pituitary Adenomas Is Associated with Aggressive Tumor Features
por: Kadioglu, Pinar, et al.
Publicado: (2020)